AstraZeneca seeks US approval for new COVID treatment

AstraZeneca requests emergency use authorization for its new COVID treatment for those who don't develop strong immune response after vax.

Arutz Sheva Staff ,

AstraZeneca
AstraZeneca
iStock



top